Skip to main content
Livermore
Livermore
ZHEN

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
8,050
Value
$203.7K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ACAD by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,050$203.7K<0.1%+150+1.9%AddedHolders
Q1 20267,900$175.9K<0.1%00.0%UnchangedHolders
Q4 20257,900$211.0K<0.1%−16,000−66.9%ReducedHolders
Q3 202523,900$510.0K<0.1%−17,800−42.7%ReducedHolders
Q2 202541,700$899.5K<0.1%−18,750−31.0%ReducedHolders
Q1 202560,450$1.00M<0.1%00.0%UnchangedHolders
Q4 202460,450$1.11M<0.1%00.0%UnchangedHolders
Q3 202460,450$929.7K<0.1%00.0%UnchangedHolders
Q2 202460,450$982.3K<0.1%00.0%UnchangedHolders
Q1 202460,450$1.12M<0.1%−3,050−4.8%ReducedHolders
Q4 202363,500$1.99M<0.1%00.0%UnchangedHolders
Q3 202363,500$1.32M<0.1%00.0%UnchangedHolders
Q2 202363,500$1.52M<0.1%00.0%UnchangedHolders
Q1 202363,500$1.20M<0.1%00.0%UnchangedHolders
Q4 202263,500$1.01M<0.1%+23,500+58.8%AddedHolders
Q3 202240,000$654.0K<0.1%−101,470−71.7%ReducedHolders
Q2 2022141,470$1.99M<0.1%+101,470+253.7%AddedHolders
Q1 202240,000$969.0K<0.1%+10,220+34.3%AddedHolders
Q4 202129,780$695.0K<0.1%+29,780NewHolders
Q2 20210$00.0%−59,702−100.0%Sold outHolders
Q1 202159,702$1.54M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.